Aavant Research vs Polaris Peptides
Independent side-by-side comparison across the 4 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Aavant Research
A grades on Tirzepatide (9 tests, avg 8.7) and Semaglutide (11 tests). Tighter score consistency than top peers.
Aavant Research full review →Polaris Peptides
9 peptides with 97 lab tests. Tirzepatide and PT-141 grade A; Retatrutide drops to D due to wider score variance.
Polaris Peptides full review →Side-by-side breakdown
| PEPTIDE | AAVANT RESEARCH | POLARIS PEPTIDES | WINNER |
|---|---|---|---|
| Tirzepatide |
8.7
B+ (9 tests)
|
8.8
B+ (15 tests)
|
Polaris Peptides |
| Retatrutide |
8.5
B+ (8 tests)
|
7.3
B (26 tests)
|
Aavant Research |
| Semaglutide |
8.5
B+ (11 tests)
|
6.9
B (16 tests)
|
Aavant Research |
| Ipamorelin |
8.2
B+ (5 tests)
|
8.0
B+ (5 tests)
|
Aavant Research |
| GHK-Cu |
—(not sold)
|
8.8
B+ (8 tests)
|
Polaris Peptides only |
| BPC-157 |
—(not sold)
|
5.4
C (11 tests)
|
Polaris Peptides only |
Which to choose
Across the 4 peptides both vendors sell, Aavant Research scores higher on 2, Polaris Peptides scores higher on 0, and 2 are within 0.3 points (effectively tied). Polaris Peptides additionally sells GHK-Cu, BPC-157; Aavant Research does not.
Choose Aavant Research for: Retatrutide, Semaglutide.
Either works for Tirzepatide, Ipamorelin — composite scores are within 0.3 points.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Aavant Research review · Polaris Peptides review